Sources | Names Used |
---|---|
CTRPv2 | vorinostat:navitoclax (4:1 mol/mol) |
PharmacoGx | vorinostat:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DOCK1 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
mRNA | PFDN2 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | ERRFI1 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | BOLA3 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | UAP1 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | MCL1 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | THEM4 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
mRNA | MRPL9 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | DRAP1 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |